ACULAR LS®

Drug Information Related Patent
Hold Company
ABBVIE
Dosage and Administration
SOLUTION/DROPS;OPHTHALMIC
Specification
0.4%
Indication
ACULAR LS® is used to reduce eye pain after corneal refractive surgery and calcination/sting.
API
KETOROLAC TROMETHAMINE
API Structure
Drug Patent
Patent NoExpiration Date
80083382027/5/24
8008338*PED2027/11/24
82072152024/5/28
8207215*PED2024/11/28
83779822024/5/28
8377982*PED2024/11/28
85414632024/5/28
8541463*PED2024/11/28
86481072024/5/28
89069502024/5/28
89462812024/5/28
92161672024/5/28
API Patent
Patent NoExpiration Date
80083382027/5/24
8008338*PED2027/11/24
82072152024/5/28
8207215*PED2024/11/28
83779822024/5/28
8377982*PED2024/11/28
85414632024/5/28
8541463*PED2024/11/28
86481072024/5/28
89069502024/5/28
89462812024/5/28
92161672024/5/28
HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

CONTACT US
  • Tel:
  • E-mail:
  • Address:
  • WhatsAPP
    WhatsAPP
Privacy Policy | Cookie Policy
Copyright © Protheragen-ING. All Rights Reserved.
dcat
Member of
dcat
Top